{"disease":{"id":"thymidine-kinase-2-deficiency-tk2d","name":"thymidine kinase 2 deficiency tk2d"},"drugs":{"marketed":[{"drug_id":"doxribtimine","indication_name":"thymidine kinase 2 deficiency (TK2d)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Kygevvi","generic_name":"DOXRIBTIMINE","company_name":"Ucb Inc","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":51,"revenue":null,"mechanism":"Kygevvi works by replacing the deficient enzyme thymidine kinase 2 in patients with TK2d."},{"drug_id":"doxecitine","indication_name":"thymidine kinase 2 deficiency (TK2d)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Kygevvi","generic_name":"DOXECITINE","company_name":"Ucb Inc","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":53,"revenue":null,"mechanism":"KYGEVVI incorporates pyrimidine nucleosides into skeletal muscle mitochondrial DNA, restoring mitochondrial DNA copy number."}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}